Select therapeutic use:
Indications for NEEVO DHA:
Nutritional supplement during pregnancy, prenatal, and postnatal periods in women with dietary needs for the biologically active form of folate, who are at risk for hyperhomocysteinemia, impaired folic acid absorption, and/or impaired folic acid metabolism due to 677C>T mutations in the MTHFR gene.
1 cap daily.
Wilson's disease. Hemochromatosis. Treatment of pernicious or other megaloblastic anemias.
Folic acid may mask pernicious anemia. DHA: bleeding diatheses.
May antagonize levodopa, phenytoin. DHA: avoid anticoagulants.